Julie Clements

Covance (United Kingdom)

Papers

1

Total Citations

30

H-Index

1

About

Julie Clements is a leading researcher in genetic toxicology, with a focus on developing innovative methods for assessing the genotoxicity of complex aerosols and gaseous mixtures, particularly mainstream cigarette smoke. Her most-cited work, "A method for assessment of the genotoxicity of mainstream cigarette-smoke by use of the bacterial reverse-mutation assay and an aerosol-based exposure system" (2014, 30 citations), addresses a critical gap in toxicological testing: the lack of widely accepted protocols for evaluating the mutagenic potential of whole smoke. By adapting the standard bacterial reverse-mutation (Ames) assay to an aerosol-based exposure system, Clements pioneered a more physiologically relevant approach, enabling direct testing of cigarette smoke without the confounding effects of particle trapping or solvent extraction. This contribution has been instrumental in advancing regulatory science, offering a practical tool for tobacco product evaluation and harm reduction research. Her work underscores the importance of bridging traditional in vitro assays with real-world exposure scenarios, marking her as a key figure in the evolution of genetic toxicology testing methodologies.

Research Focus

Key Achievements

1
H-Index
1
Papers
30
Total Citations
30
Avg Citations/Paper
🏆 Most Cited Paper
A method for assessment of the genotoxicity of mainstream cigarette-smoke by use of the bacterial reverse-mutation assay and an aerosol-based exposure system
30 citations · 2014
📈 Most Prolific Year: 2014 (1 Papers)
🤝 Key Collaborators: 6
🏛 Institutions: Covance (United Kingdom)

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago